Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

CPIX holding history

Cumberland Pharmaceuticals Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPIX overviewAll 13F holders of CPIXFull Q2 2026 holdings

Shares (Q2 2026)
26,339
Value
$170.7K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of CPIX by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202626,339$170.7K<0.1%+21,150+407.6%AddedHolders
Q1 20265,189$16.9K<0.1%−10,197−66.3%ReducedHolders
Q4 202515,386$61.2K<0.1%+14,559+1,760.5%AddedHolders
Q3 2025827$2.58K<0.1%−7,991−90.6%ReducedHolders
Q2 20258,818$29.5K<0.1%+3,481+65.2%AddedHolders
Q1 20255,337$22.6K<0.1%−2,858−34.9%ReducedHolders
Q4 20248,195$19.4K<0.1%−1,476−15.3%ReducedHolders
Q3 20249,671$12.4K<0.1%+2,801+40.8%AddedHolders
Q2 20246,870$10.5K<0.1%+5,077+283.2%AddedHolders
Q1 20241,793$3.01K<0.1%+1,683+1,530.0%AddedHolders
Q4 2023110$197<0.1%+110NewHolders
Q3 20230$00.0%−8,616−100.0%Sold outHolders
Q2 20238,616$12.7K<0.1%+5,792+205.1%AddedHolders
Q1 20232,824$5.51K<0.1%−899−24.1%ReducedHolders
Q4 20223,723$8.38K<0.1%+3,723NewHolders
Q3 20220$00.0%−3,783−100.0%Sold outHolders
Q2 20223,783$8.00K<0.1%+503+15.3%AddedHolders
Q1 20223,280$9.00K<0.1%+3,280NewHolders
Q4 20210$00.0%−1,933−100.0%Sold outHolders
Q3 20211,933$5.00K<0.1%+1,468+315.7%AddedHolders
Q2 2021465$1.00K<0.1%−2,514−84.4%ReducedHolders
Q1 20212,979$9.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.